이상반응 보고
| VAERS ID | 2296230 |
|---|---|
| 성별 | 여성 |
| 나이 | 53세 |
| 주 코드 | FR |
| 제약회사 | JANSSEN |
| 로트 번호 | |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-03-17 |
| 발병일 | 2021-03-17 |
| 상태 | 회복 |
증상
- 두통(Headache)
- 현기증(Dizziness)
- 호흡곤란(Dyspnoea)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
DIZZINESS; SHORTNESS OF BREATH; HEADACHE; This spontaneous report received from a health care professional via a Regulatory authority (RA, ZA-SAHPRA-300055198) concerned a 53 year old female of unspecified race and ethnicity.
The patient's height, and weight were not reported.
No past medical history or concurrent conditions were reported.
The patient received covid-19 vaccine ad26.
cov2.
s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total administered on 17-MAR-2021 for covid-19 vaccination.
Duration of adminstration was 1 day.
Age at time of vaccination 53 years old.
The batch number was not reported.
The Company is unable to perform follow-up to request batch/lot numbers.
No concomitant medications were reported.
On 17-MAR-2021, the patient experienced dizziness, shortness of breath and headache.
The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
The patient recovered from dizziness, shortness of breath, and headache.
This report was serious (Other Medically Important Condition).
; Sender's Comments: V0:20220544261-COVID-19 VACCINE AD26.
COV2.
S-Dizziness,Shortness of breath.
The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility.
There is no information on any other factors potentially associated with the event(s).
Therefore, this event(s) is considered unassessable.
20220544261-COVID-19 VACCINE AD26.
COV2.
S-Headache.
This event(s) is labeled per RSI and is therefore considered potentially related.